| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3999339 | Urologic Oncology: Seminars and Original Investigations | 2016 | 8 Pages |
Abstract
Our results were similar compared with the previous results from the phase II study with a distinct activity with an ORR of 44%, and a long-term OS in 21% of the patients. Our data support the recommendation to use GOP ± secondary surgery in patients with multiply refractory metastatic GCC.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Christoph M.D., Karin M.D., Anja M.D., Annette M.D., Marcus M.D., Mareike M.D., Viktor M.D., Richard M.D., Johannes M.D., Maike M.D., Carsten M.D.,